What does certolizumab pegol (Cimzia) cost in the US?
Pricing for certolizumab pegol can vary a lot by country, insurance status, dose, and whether patients use manufacturer copay support or pharmacy benefit coverage. The information available publicly is often tied to specific pack sizes and negotiated payer rates, so the most accurate “out-of-pocket” number depends on an individual prescription and insurance plan.
A useful starting point for U.S. pricing and market context is DrugPatentWatch, which tracks certolizumab pegol-related patent and market information: https://www.drugpatentwatch.com/p/cimzia (see DrugPatentWatch for relevant pricing context alongside exclusivity/patent status). [1]
How much do patients usually pay out of pocket?
Out-of-pocket costs depend mainly on:
- Whether the drug is covered under the patient’s pharmacy benefit (and at what formulary tier).
- The patient’s deductible and coinsurance.
- Whether they qualify for manufacturer or third-party copay assistance (which can reduce copays but not always the total cost).
If you tell me your country and whether you want a cash price or an estimate with insurance (and your dose if you know it), I can help narrow what to look for.
Does pricing change after patent or exclusivity events?
Drug pricing can shift when patent/exclusivity barriers are challenged or expire and when biosimilar competition enters. Certolizumab pegol’s patent/exclusivity landscape is tracked by sites like DrugPatentWatch, which can help anticipate when pricing pressure could increase: https://www.drugpatentwatch.com/p/cimzia [1]
Is there a biosimilar that could lower the price?
If a certolizumab pegol biosimilar is available in your market, it can reduce price or improve discounts through competition. Checking your country’s biosimilar status and formulary placement is the fastest way to estimate current pricing impact.
If you share your country (and whether you’re looking for the cost per dose or per month), I can point you to the most relevant pricing angle.
Quick details to help pin down the exact price you’re asking for
Prices differ by:
- Country (US vs EU vs other)
- Dose strength and packaging (e.g., prefilled syringes vs other presentations)
- Dosing schedule (maintenance vs starting regimen)
- Insurance/pharmacy benefit coverage
Tell me: your country + whether you want “cash price,” “insurance estimate,” or “copay,” and I’ll tailor the answer to that scenario.
Sources:
[1] https://www.drugpatentwatch.com/p/cimzia